epigallocatechin gallate has been researched along with Cancer of Mouth in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 18 (54.55) | 24.3611 |
| 2020's | 4 (12.12) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, T; Kon, M; Ogasawara, M; Ohashi, Y; Yamada, H | 1 |
| Bai, J; Cai, X; Jing, F; Li, T; Zhang, H; Zhang, J; Zhou, X; Zhu, L | 1 |
| Chen, L; Guo, X; Hu, Y; Li, L; Liang, G; Zhang, G | 1 |
| Chen, HM; Chen, HY; Chiang, CP; Li, WC; Lin, HY; Wei, YC; Yang, H | 1 |
| López Jornet, P; Pons-Fuster López, E; Wang, QT; Wei, W | 1 |
| Gómez García, F; López Jornet, P; Pons-Fuster López, E | 1 |
| Kiyoshima, T; Kobayashi, M; Matsuda, S; Ohmori, M; Ohta, K; Ryoke, T; Sano, K; Yamamoto, S; Yoshida, H; Yoshimura, H | 1 |
| Chaushu, G; Dayan, A; Dayan, D; Salo, T; Vered, M; Zlotogorski, A | 1 |
| Chung, WY; Hwang, YS; Park, KK | 1 |
| Iriti, M; Varoni, EM | 1 |
| Forester, SC; Lambert, JD; Tao, L | 1 |
| Lambert, JD; Park, JY; Tao, L | 1 |
| Chen, WT; Chen, YJ; Chung, LC; Feng, TH; Juang, HH; Lee, JC | 1 |
| Chen, LL; Geng, Y; Han, WF; Su, JS | 1 |
| Messadi, DV; Sato, K | 1 |
| Chen, FA; Chiang, JH; Chiang, NN; Horng, CT; Hsu, YM; Lee, CF; Lu, CC; Tsai, FJ; Yang, JS; Yuan, CH | 1 |
| Hara, A; Hatakeyama, D; Kato, K; Long, NK; Makita, H; Mori, H; Shibata, T; Toida, M; Yamashita, T | 1 |
| Chen, YJ; Cheng, CW; Kao, JY; Kao, MC; Kuo, DH; Lin, YC; Lin, YH; Liu, JY; Shieh, PC; Way, TD | 1 |
| Choi, EC; Hwang, HS; Kang, SU; Kim, CH; Koh, YW; Lee, MH; Lee, Y; Park, R; Pyun, J | 1 |
| Chen, PN; Chou, MY; Chu, SC; Hsieh, YS; Kuo, WH; Lin, JK | 1 |
| Aizenbud, D; Levy, Y; Narotzki, B; Reznick, AZ | 1 |
| Chang, YC; Ho, YC; Lee, SS; Tsai, CH; Yu, CC | 1 |
| Amagaya, S; Chang, CM; Chang, PY; Chen, MY; Jao, HY; Kuo, SC; Lee, CY; Lu, CC; Tu, MG; Yang, JS | 1 |
| Chang, KW; Chen, YM; Fann, MJ; Kao, SY; Lin, SC; Liu, CJ; Lu, SY; Wang, CP | 1 |
| Liu, J; Mei, Y; Wei, D | 1 |
| Chung, FL; Herzog, CR; Schwartz, J; Yang, YM | 1 |
| Babich, H; Krupka, ME; Nissim, HA; Zuckerbraun, HL | 1 |
| Chang, KW; Chiang, WC; Lin, SC; Liu, CJ; Wong, YK | 1 |
| Chang, KW; Hsu, HC; Ko, SY; Lin, SC; Liu, TY | 1 |
| Aranbayeva, Z; Dickinson, D; Digumarthi, H; Hsu, S; Lewis, J; Messer, R; Osaki, T; Qin, H; Schuster, GS; Wataha, J; Yamamoto, T | 1 |
| Chang, YC; Chou, MY; Ho, YC; Peng, CY; Yang, SF | 1 |
| Chou, TC; Edelstein, D; Khafif, A; Sacks, PG; Schantz, SP | 1 |
| Chen, L; Lee, MJ; Yang, CS | 1 |
5 review(s) available for epigallocatechin gallate and Cancer of Mouth
| Article | Year |
|---|---|
Nutraceuticals as new treatment approaches for oral cancer: II. Green tea extracts and resveratrol.
Topics: Animals; Catechin; Dietary Supplements; Humans; Mice; Mouth Neoplasms; Plant Extracts; Resveratrol; Stilbenes; Tea | 2013 |
Chemopreventive potential of flavonoids in oral squamous cell carcinoma in human studies.
Topics: Administration, Mucosal; Anticarcinogenic Agents; Catechin; Chemoprevention; Drug Delivery Systems; Flavonoids; Fruit; Humans; Mouth Neoplasms; Nanoparticles; Polyphenols; Randomized Controlled Trials as Topic; Tea | 2013 |
Oral Cancer Chernoprevention: Current Status and Future Direction.
Topics: Anticarcinogenic Agents; Carcinogenesis; Carotenoids; Catechin; Chemoprevention; Humans; Mouth Neoplasms; Plant Preparations; Precancerous Conditions; Trypsin Inhibitor, Bowman-Birk Soybean; Trypsin Inhibitors | 2016 |
Green tea: a promising natural product in oral health.
Topics: Antioxidants; Catechin; Cell Transformation, Neoplastic; Dental Caries; Halitosis; Humans; Inflammation; Influenza, Human; Mouth Neoplasms; Oral Health; Oxidative Stress; Polyphenols; Smoking; Tea | 2012 |
Tea and cancer prevention: studies in animals and humans.
Topics: Animals; Apoptosis; Caffeine; Catechin; Clinical Trials as Topic; Flavonoids; Humans; Lung Neoplasms; Mice; Mouth Neoplasms; Neoplasms; Phenols; Polyphenols; Rats; Smoking; Tea | 2003 |
28 other study(ies) available for epigallocatechin gallate and Cancer of Mouth
| Article | Year |
|---|---|
Epigallocatechin gallate stimulated histamine production and downregulated histamine H1 receptor in oral cancer cell lines expressing histidine decarboxylase.
Topics: Catechin; Cell Line; Histamine; Histidine Decarboxylase; Humans; Mouth Neoplasms; Receptors, Cell Surface; Receptors, Histamine H1 | 2022 |
Molecular mechanisms underlying the epigallocatechin-3-gallate-mediated inhibition of oral squamous cell carcinogenesis.
Topics: Carcinogenesis; Catechin; Cell Line, Tumor; Epithelial Cells; Humans; Mouth Neoplasms; Oral Submucous Fibrosis; Signal Transduction | 2023 |
Epigallocatechin-3-gallate sensitises multidrug-resistant oral carcinoma xenografts to vincristine sulfate.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Catechin; Cell Proliferation; Chick Embryo; Chickens; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Injections, Intraperitoneal; KB Cells; Mice; Mice, Nude; Mouth Neoplasms; Neoplasms, Experimental; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vincristine | 2020 |
Natural Compounds Modulate Drug Transporter Mediated Oral Cancer Treatment.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Catechin; Cell Line, Tumor; Cell Survival; Curcumin; Gefitinib; Humans; Kaplan-Meier Estimate; Mouth Neoplasms; Neoplasm Proteins; Photochemotherapy; Photosensitizing Agents | 2020 |
Potential chemotherapeutic effects of diosgenin, zoledronic acid and epigallocatechin-3-gallate on PE/CA-PJ15 oral squamous cancer cell line.
Topics: Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Diosgenin; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Imidazoles; Mouth Neoplasms; Zoledronic Acid | 2017 |
Combination of 5-Florouracil and polyphenol EGCG exerts suppressive effects on oral cancer cells exposed to radiation.
Topics: Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Therapy, Combination; Fluorouracil; Humans; Mouth Neoplasms; Radiation | 2019 |
The therapeutic potential of epigallocatechin‑3‑gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In vitro and in vivo murine xenograft study.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Epigallocatechin-3 gallate inhibits cancer invasion by repressing functional invadopodia formation in oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Catechin; Cell Membrane; Cell Movement; Cell Proliferation; Cortactin; Extracellular Matrix; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Humans; Male; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Mouth Neoplasms; Neoplasm Invasiveness; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); rhoA GTP-Binding Protein; Xenograft Model Antitumor Assays | 2013 |
The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (-)-epigallocatechin-3-gallate, in oral cells.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Catechin; Cell Line, Tumor; Fibroblasts; Gene Expression Regulation; Gingiva; Humans; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mitochondria; Mouth Neoplasms; Oxidative Stress; Reactive Oxygen Species; Tea | 2014 |
Differential prooxidative effects of the green tea polyphenol, (-)-epigallocatechin-3-gallate, in normal and oral cancer cells are related to differences in sirtuin 3 signaling.
Topics: Antioxidants; Catechin; Cell Line, Tumor; ERRalpha Estrogen-Related Receptor; Gene Expression Regulation; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Mitochondria; Mouth Neoplasms; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Polyphenols; Reactive Oxygen Species; Receptors, Estrogen; Signal Transduction; Sirtuin 3; Superoxide Dismutase; Tea; Transcription Factors | 2015 |
Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
Topics: Animals; Carcinoma, Squamous Cell; Catechin; Cell Growth Processes; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; G1 Phase Cell Cycle Checkpoints; Gene Knockdown Techniques; Head and Neck Neoplasms; Humans; Immediate-Early Proteins; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Squamous Cell Carcinoma of Head and Neck; Tumor Suppressor Proteins; Up-Regulation; Xenograft Model Antitumor Assays | 2015 |
A genome-wide study of DNA methylation modified by epigallocatechin-3-gallate in the CAL-27 cell line.
Topics: Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Computational Biology; DNA Methylation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Humans; Mouth Neoplasms; Signal Transduction | 2015 |
Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling.
Topics: Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Autophagy-Related Proteins; Caspase 3; Caspase 9; Catechin; Cell Line, Tumor; Cisplatin; Down-Regulation; Humans; Microscopy, Fluorescence; Mouth Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT3 Transcription Factor | 2017 |
Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells.
Topics: Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Movement; DNA Methylation; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Membrane Glycoproteins; Mouth Neoplasms; Neoplasm Invasiveness; Polymerase Chain Reaction; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; Tea | 2008 |
Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells.
Topics: Catechin; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Enzymologic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Janus Kinases; Mouth Neoplasms; Protein Kinase C-delta; Signal Transduction; STAT1 Transcription Factor | 2010 |
Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met.
Topics: Animals; Catechin; Cell Movement; Cell Proliferation; Chemoprevention; Disease Progression; Female; Hepatocyte Growth Factor; Humans; KB Cells; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mouth Neoplasms; Neoplasm Invasiveness; Proto-Oncogene Proteins c-met; Signal Transduction; Tea | 2011 |
Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells.
Topics: Base Sequence; Carcinoma, Squamous Cell; Catechin; Cell Division; Cell Line, Tumor; DNA Primers; Epithelial-Mesenchymal Transition; Fluorescent Antibody Technique; Humans; Mouth Neoplasms; Neoplasm Invasiveness; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Heat shock protein 27 expression in areca quid chewing-associated oral squamous cell carcinomas.
Topics: Acetylcysteine; Areca; Arecoline; Carcinoma, Squamous Cell; Case-Control Studies; Catechin; Cyclooxygenase 2 Inhibitors; Down-Regulation; Female; Flavonoids; Gene Expression; Gene Expression Regulation, Neoplastic; HSP27 Heat-Shock Proteins; Humans; Imidazoles; Male; Middle Aged; Mouth Neoplasms; Nitrobenzenes; Pyridines; Quercetin; Sulfonamides | 2012 |
Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Drug Synergism; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gefitinib; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mouth Neoplasms; Neoplasm Metastasis; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Wound Healing | 2012 |
Regulation of IGFBP-5 expression during tumourigenesis and differentiation of oral keratinocytes.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Catechin; Cell Differentiation; Cell Transformation, Neoplastic; Down-Regulation; Gene Expression Regulation, Neoplastic; Gene Library; Humans; Insulin-Like Growth Factor Binding Protein 5; Keratinocytes; Male; Middle Aged; Mouth Neoplasms; Neoplasm Proteins; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Up-Regulation | 2002 |
Quantification of doxorubicin and validation of reversal effect of tea polyphenols on multidrug resistance in human carcinoma cells.
Topics: Carcinoma, Squamous Cell; Catechin; Cell Division; Cell Survival; Chromatography, High Pressure Liquid; Doxorubicin; Drug Resistance, Multiple; Flavonoids; Humans; Mouth Neoplasms; Phenols; Polymers; Tea; Tumor Cells, Cultured | 2003 |
Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity.
Topics: Antioxidants; Apoptosis; Carcinoma, Squamous Cell; Catechin; Cell Survival; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fibroblasts; Gingiva; Humans; Mouth Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2005 |
Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3-gallate suppress MMP-13 expression.
Topics: Adult; Aged; Anticarcinogenic Agents; Blotting, Western; Carcinoma, Squamous Cell; Catechin; Collagenases; Electrophoresis, Polyacrylamide Gel; Humans; Immunohistochemistry; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Protease Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2006 |
The repressive effect of green tea ingredients on amyloid precursor protein (APP) expression in oral carcinoma cells in vitro and in vivo.
Topics: Amyloid beta-Protein Precursor; Animals; Blotting, Western; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Phytotherapy; Plant Preparations; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea | 2007 |
EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase.
Topics: Animals; Anthracenes; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Catechin; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p57; Cytochromes c; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Nude; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Signal Transduction; Transfection; Xenograft Model Antitumor Assays | 2007 |
Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
Topics: Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Cell Survival; Epithelial Cells; Humans; Matrix Metalloproteinase Inhibitors; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Plant Extracts; Tea; Urokinase-Type Plasminogen Activator | 2007 |
Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells.
Topics: Anticarcinogenic Agents; Catechin; Cells, Cultured; Curcumin; Dose-Response Relationship, Drug; Drug Synergism; Epithelial Cells; Flow Cytometry; Humans; Mouth Neoplasms; Precancerous Conditions; Tea | 1998 |
Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies.
Topics: Absorption; Adult; Anticarcinogenic Agents; Beverages; Capsules; Catechin; Drinking; Esophageal Neoplasms; Esterases; Female; Flavonoids; Free Radical Scavengers; Half-Life; Humans; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Saliva; Tea | 1999 |